Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Anaphylaxis (15)
  • Asthma (16)
  • Basic immunology (1)
  • Biologicals (5)
  • Biomarkers (4)
  • COVID19 (1)
  • Drug allergy (3)
  • Environmental allergy and climate change (1)
  • Epidemiology (9)
  • Food allergy (9)
  • Genomics and proteomics (1)
  • Immune deficiencies and autoimmunity (2)
  • Infections (3)
  • Insect venom hypersensitivities (1)
  • x Mastocytosis and mast cells (4)
  • Microbiome (1)
  • Occupational allergy (2)
  • Pediatrics (10)
Poster available until
Poster categories
  • Thematic Poster Session (3)
keywords
Session Reference
  • L-TPS11 (1)
  • L-TPS13 (1)
  • L-TPS18 (1)
  • TPS11 (1)
  • TPS13 (1)
  • TPS15 (2)
  • TPS16 (1)
  • x TPS37 (3)
  • x TPS56 (1)
  • TPS71 (11)
4 results
Thumbnail

- D3.117 - Targeting Mast Cells with Briquilimab, an Anti-Human c-Kit (CD117) Antibody, Mitigates COPD-Like Features in an Allergen and Cigarette Smoke-Exacerbated Asthma Model Using Humanized h/mCD117 Mice

Thumbnail

D2.262 - Measurement of tryptasemia in a university hospital: prescribing reality versus recommendations

Thumbnail

D2.269 - Diagnostic challenges in evaluating diagnosis of mast cell disorder in a patient with severe allergy to hymenoptera venom

Thumbnail

D2.273 - Kratom-induced anaphylaxis revealed Monoclonal Mast Cells of Clinical Significance

Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM